The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C.
about
The pathogenesis of Niemann-Pick type C disease: a role for autophagy?Diagnostic workup and management of patients with suspected Niemann-Pick type C diseaseNiemann-Pick disease treatment: a systematic review of clinical trialsMutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C-related protein reveals a primordial role in subcellular sphingolipid distribution.Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease.Identification of a pharmaceutical compound that partially corrects the Niemann-Pick C phenotype in cultured cells.Cell polarity and PIN protein positioning in Arabidopsis require STEROL METHYLTRANSFERASE1 function.Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type CSpectrum of phenotypic variability in Niemann-Pick type C disease: A cause of delayed diagnosis.Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.Niemann-Pick disease type C: two cases and an update.Allopregnanolone treatment, both as a single injection or repetitively, delays demyelination and enhances survival of Niemann-Pick C mice.Niemann-Pick type C pathogenesis and treatment: from statins to sugars.Treatment of a child diagnosed with Niemann-Pick disease type C with miglustat: a case report in Brazil.Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.Cholesterol: its regulation and role in central nervous system disorders.The natural history of Niemann-Pick disease type C in the UK.Statins in the spectrum of neurologic disease.Niemann-Pick type C disease proteins: orphan transporters or membrane rheostats?The potential of histone deacetylase inhibitors in Niemann - Pick type C disease.Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease.Niemann-Pick Disease Type C: from molecule to clinic.Treatable metabolic psychoses that go undetected: what Niemann-Pick type C can teach us.Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.Niemann-Pick C1 functions in regulating lysosomal amine content.Role of LDL cholesterol and endolysosomes in amyloidogenesis and Alzheimer's disease.Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD.Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk.Treatment of hyperlipidemia associated with Niemann-Pick disease type B by fenofibrate.Consensus clinical management guidelines for Niemann-Pick disease type C.Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC.Miglustat in Niemann-Pick disease type C patients: a review
P2860
Q24650767-C787B3C1-6D05-4411-AE06-11FE9F800B02Q26748586-347AC388-F035-4F3A-BD97-AC5FAF096978Q26774861-87055F71-CC10-4510-8FD2-6D6F83F22728Q27939998-82955DB5-864E-41A1-849B-32B580BE48D2Q30645985-4FB35310-5219-4A38-AB62-3C8B891B53C8Q33184779-7D38CC85-6947-40E9-8BF2-6F06090C3155Q33338156-85150FF2-D3DC-4BCC-919C-27BD94E02BE6Q33560665-EBB3A22A-A7C1-4040-BD80-342EE8B914CCQ33776056-1B6F45D0-25C2-48CC-B57C-A4344023F42AQ34053107-74FEBF75-202A-4E57-BAD7-ECCE61FEB5E3Q34069183-908167D1-D64D-44D8-9996-09258761AFDEQ34097290-4159E2F8-373E-4FEE-8F8A-96181B713112Q34465743-30A0870F-487F-43FF-AFF4-EA79E66F7FC3Q34632493-D927E36F-DD09-422B-9BEC-CC3EC0A94653Q34860824-5013209A-A1B2-4EFB-8B31-6AADE855FB66Q35103069-A6954DA9-C850-4E4E-8A6E-4A4B84C51CF4Q36355194-E05DAFDA-C940-48FF-9432-7EC271741248Q36679497-6FCBDED6-4647-4336-B896-DF19CBA79712Q37119244-4B4D0FBD-ED40-45FF-A776-72A2D7B2A98BQ37247214-882456BC-AA4C-4623-9E7C-5380B7BC8F06Q37380311-A44A51DB-0131-442F-96ED-A001ACB40579Q37439680-905B662F-7752-4434-8779-29EDA4DD24AFQ37536340-F801C60E-4935-464C-A3F6-6E3F18F576A0Q38022679-721816DF-EE2E-4088-AC9B-6969D8CFD42EQ38139309-63B83AD7-1C9B-4EC9-A954-0F2C896D045CQ42426518-7CF9AE0F-CB85-4417-8741-CA22465F80ADQ42736295-A42866EB-F702-4C03-9CD3-31628EBDFA1EQ43115550-36061B5E-C1C1-4A45-AA31-14A0C986B949Q46256722-6AB8CAD7-184C-4C80-8FB0-1DF175F0AFD2Q46740984-5167E515-C1B0-4978-B4FB-032A4370861CQ52602028-0E6952EB-3A89-418D-8C3E-A321C5C0C8F1Q52670912-81EF8095-C460-469B-A437-D761C226C2DAQ58778074-C05D4C3A-A07A-41EF-99DB-0E34FD907701
P2860
The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The effect of cholesterol-lowe ...... n Niemann-Pick disease type C.
@en
The effect of cholesterol-lowe ...... n Niemann-Pick disease type C.
@nl
type
label
The effect of cholesterol-lowe ...... n Niemann-Pick disease type C.
@en
The effect of cholesterol-lowe ...... n Niemann-Pick disease type C.
@nl
prefLabel
The effect of cholesterol-lowe ...... n Niemann-Pick disease type C.
@en
The effect of cholesterol-lowe ...... n Niemann-Pick disease type C.
@nl
P2093
P1433
P1476
The effect of cholesterol-lowe ...... n Niemann-Pick disease type C.
@en
P2093
Di Bisceglie AM
Higgins JJ
Patterson MC
Pentchev PG
Schiffmann R
P356
10.1212/WNL.43.1_PART_1.61
P407
P577
1993-01-01T00:00:00Z